Medical marketing news, white papers, reports, and events from PharmaLeaders. New content daily, on our website and delivered right to your inbox.
Hospitals say 340B should not be part of Trump's drug price agenda Reforming the 340B program should not be undertaken as part of President Donald Trump’s effort to lower drug prices, hospital industry representatives are telling HHS. The suggestion came in comments responding to the Trump Administration’s Blueprint to Lower Drug Prices released in May. Responses to the document were due July 16. The comments come as HHS Secretary ... Read More
FEMA's unpreparednesss hurt providers in 2017 hurricane season The Federal Emergency Management Agency was acutely unprepared for the unprecedented 2017 hurricane season, leaving many providers in Puerto Rico, Texas and Florida in the dark as they tried to recover. FEMA said in an “after-action” report issued Friday that it didn’t have the infrastructure in place to share information quickly enough to properly react to ... Read More
Hospital execs say inpatient volume growth isn't rebounding A new survey of hospital administrators shows their inpatient volumes continue to slump as patients flock to cheaper outpatient settings for services like heart surgeries, hip replacements and urologic procedures. Leerink Partners, the investment bank that released the survey of nearly 50 mostly not-for-profit hospital administrators, wrote that its results are “modestly positive” for hospitals, whose ... Read More
Urgent care clinics overprescribe antibiotics Nearly half of antibiotic prescriptions written in an urgent care center were for conditions that did not warrant their use, according to a new study. In an analysis published Monday in JAMA Internal Medicine, researchers found 46% of urgent care patients in 2014 had conditions that did not require an antibiotic received a prescription for one ... Read More
Pediatric Gene Therapy The European approvals of Glybera® in 2012 and Strimvelis® in 2016 seem likely to be the vanguard of the therapeutic revolution heralded by the decoding of the human genome. Both of these treatments originated from academic centers of excellence and became the subjects of agreements with pharmaceutical companies (Uniqure/Chiesi and GSK, respectively) with the experience ... Read More
The Great DTC Shake-Up Patient perspectives on direct-to-consumer advertising This in-depth eyeforpharma whitepaper, which we developed with Health Perspectives Group explores the evolving role of DTC advertising with direct feedback from patient’s – including exclusive results from the recent “DTC Attitudes, Behaviours and Preferences” patient study conducted by Health Stories Project – Insights, (HSPi). Read More